The scope and limitations of balneological treatment: diabetes, chronic Bright's disease, renal calculus, dyspepsia, obesity, and cachexia

被引：0
|
作者：
Wohlmann, Arthur
机构：
来源：
NEW ZEALAND MEDICAL JOURNAL | 2005年 / 118卷 / 1210期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 36 条
  • [31] Active vitamin D treatment does not modify arterial stiffness and markers of cardio-renal risk in patients with type 2 diabetes and stage 3 chronic kidney disease
    Karalliedde, J.
    Fountoulakis, N.
    Ayis, S.
    Panagiotou, A.
    Flaquer, M.
    Stoilov, S.
    Maltese, G.
    Viberti, G.
    Thomas, S.
    Gnudi, L.
    [J]. DIABETOLOGIA, 2019, 62 : S482 - S483
  • [32] COMMENT ON TANG ET AL. The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130-137
    Foussard, Ninon
    Larroumet, Alice
    Ferriere, Amandine
    Blanco, Laurence
    Mohammedi, Kamel
    Rigalleau, Vincent
    [J]. DIABETES CARE, 2023, 46 (05) : E115 - E115
  • [33] RESPONSE TO COMMENT ON TANG ET AL. The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130-137
    Tang, Mengyao
    Kalim, Sahir
    [J]. DIABETES CARE, 2023, 46 (05) : E116 - E116
  • [34] Concomitant treatment with insulin and sodium-glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score-matched analysis
    Toyoda, Masao
    Saito, Nobumichi
    Kimura, Moritsugu
    Hatori, Nobuo
    Tamura, Kouichi
    Miyakawa, Masaaki
    Sato, Kazuyoshi
    Kanamori, Akira
    Kobayashi, Kazuo
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (09) : 1520 - 1527
  • [35] P.64 Active Vitamin D Treatment Does Not Improve Arterial Stiffness and Markers of Cardio-Renal Risk in Patients with Type 2 Diabetes and Stage 3 Chronic Kidney Disease: a Randomised Controlled Trial
    Nikolaos Fountoulakis
    Salma Ayis
    Anastasios Mangelis
    Angeliki Panagiotou
    Maria Flaquer
    Stanimir Stoilov
    Giuseppe Maltese
    GianCarlo Viberti
    Stephen Thomas
    Luigi Gnudi
    Janaka Karalliedde
    [J]. Artery Research, 2020, 26 (Suppl 1) : S88 - S88
  • [36] Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease
    Tsukamoto, Shunichiro
    Kobayashi, Kazuo
    Toyoda, Masao
    Tone, Atsuhito
    Kawanami, Daiji
    Suzuki, Daisuke
    Tsuriya, Daisuke
    Machimura, Hideo
    Shimura, Hidetoshi
    Wakui, Hiromichi
    Takeda, Hiroshi
    Yokomizo, Hisashi
    Takeshita, Kei
    Chin, Keiichi
    Kanasaki, Keizo
    Miyauchi, Masaaki
    Saburi, Masuo
    Morita, Miwa
    Yomota, Miwako
    Kimura, Moritsugu
    Hatori, Nobuo
    Nakajima, Shinichi
    Ito, Shun
    Murata, Takashi
    Matsushita, Takaya
    Furuki, Takayuki
    Hashimoto, Takuya
    Umezono, Tomoya
    Muta, Yoshimi
    Takashi, Yuichi
    Tamura, Kouichi
    [J]. DIABETES OBESITY & METABOLISM, 2024, 26 (08): : 3248 - 3260
1234